JPMORGAN CHASE & CO - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$491,554
+36.3%
28,299
+10.5%
0.00%
Q2 2023$360,729
+31.2%
25,620
+0.2%
0.00%
Q1 2023$275,000
+92492.6%
25,561
+28.9%
0.00%
Q4 2022$297
-99.9%
19,825
+2.8%
0.00%
Q3 2022$248,000
+41.7%
19,288
+6.1%
0.00%
Q2 2022$175,000
-1.1%
18,173
+2.0%
0.00%
Q1 2022$177,000
+4.7%
17,825
+23.8%
0.00%
Q4 2021$169,000
+13.4%
14,394
+9.3%
0.00%
Q3 2021$149,000
-16.3%
13,167
+3.2%
0.00%
Q2 2021$178,000
-4.8%
12,756
+26.6%
0.00%
Q1 2021$187,000
-11.0%
10,073
-15.2%
0.00%
Q4 2020$210,000
+35.5%
11,885
+19.3%
0.00%
Q3 2020$155,000
-4.9%
9,965
+55.3%
0.00%
Q2 2020$163,000
+19.0%
6,415
-27.9%
0.00%
Q1 2020$137,000
+168.6%
8,895
+94.2%
0.00%
Q4 2019$51,000
+30.8%
4,581
+0.2%
0.00%
Q3 2019$39,000
-25.0%
4,574
+19.4%
0.00%
Q2 2019$52,0000.0%3,832
+33.1%
0.00%
Q1 2019$52,000
+10.6%
2,880
+73.7%
0.00%
Q4 2018$47,000
+23.7%
1,658
+10.3%
0.00%
Q3 2018$38,0001,5030.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,374,392$36,376,0004.43%
Opaleye Management Inc. 338,000$8,778,0001.72%
Lion Point Capital, LP 495,748$7,594,0001.67%
Fairmount Funds Management LLC 212,746$3,259,0001.38%
Vivo Capital, LLC 1,151,622$17,643,0001.02%
Spearhead Capital Advisors, LLC 270,117$4,138,0000.79%
Integral Health Asset Management, LLC 120,000$1,838,0000.56%
Endurant Capital Management LP 117,480$1,800,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 259,990$3,983,0000.39%
Ikarian Capital, LLC 342,998$5,254,0000.38%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders